Cochrane Abstracts
Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer New
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Weekly Versus Tri‐weekly Paclitaxel With Carboplatin for First‐line Treatment in Women With Epithelial Ovarian Cancer New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431018/all/Weekly_versus_tri‐weekly_paclitaxel_with_carboplatin_for_first‐line_treatment_in_women_with_epithelial_ovarian_cancer_New. Accessed 01 June 2023.
Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431018/all/Weekly_versus_tri‐weekly_paclitaxel_with_carboplatin_for_first‐line_treatment_in_women_with_epithelial_ovarian_cancer_New. Accessed June 1, 2023.
Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431018/all/Weekly_versus_tri‐weekly_paclitaxel_with_carboplatin_for_first‐line_treatment_in_women_with_epithelial_ovarian_cancer_New
Weekly Versus Tri‐weekly Paclitaxel With Carboplatin for First‐line Treatment in Women With Epithelial Ovarian Cancer New [Internet]. In: Cochrane Abstracts. [cited 2023 June 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431018/all/Weekly_versus_tri‐weekly_paclitaxel_with_carboplatin_for_first‐line_treatment_in_women_with_epithelial_ovarian_cancer_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer New
ID - 431018
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431018/all/Weekly_versus_tri‐weekly_paclitaxel_with_carboplatin_for_first‐line_treatment_in_women_with_epithelial_ovarian_cancer_New
DB - Evidence Central
DP - Unbound Medicine
ER -
